WithdrawnNCT03883360
Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
Medication studyAges 18–35United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 35 years.
- Listed locations
- Los Angeles and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: January 2050
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 35 Years
- Official registry ID
- NCT03883360
- Official title
Show the full official title
Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles · Baltimore · Catonsville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Does this study involve medication?
Yes. The study involves medication, including Cannabidiol (CBD) and Placebo.
Who can participate?
Listed age limits: 18 years to 35 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
